Abstract Details
|
Vijayaraghava T. Rao, PhD
(argenx US Inc)
PRESENTER |
No disclosure on file |
| Samuel Ludwin, MD (Kingston General Hospital) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Robin Sawaya, MD (London Health Sciences Centre - University Hospital) | No disclosure on file |
| Craig S. Moore, PhD (Memorial University of Newfoundland) | Dr. Moore has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Jack P. Antel, MD, FAAN (Montreal Neurologic Hospital) | Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities. |